NCT05668754 Phase 2 Completed
Study of SDX in Patients With Idiopathic Hypersomnia (IH) Study sponsor: Zevra Therapeutics
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2024-02-28 Actual
Enrollment · participants 66 Actual
Source updated 2026-06-30 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-05-01 · 1 field changed
Actual enrollment decreased by 98 participants
− Before 164 participants (actual)
+ After 66 participants (actual)
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology